Optogenetic Vision Restoration Using Rhodopsin for Enhanced Sensitivity

Retinal disease is one of the most active areas of gene therapy, with clinical trials ongoing in the United States for five diseases. There are currently no treatments for patients with late-stage disease in which photoreceptors have been lost. Optogenetic gene therapies are in development, but, to...

Descripción completa

Detalles Bibliográficos
Autores principales: Gaub, Benjamin M, Berry, Michael H, Holt, Amy E, Isacoff, Ehud Y, Flannery, John G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4817926/
https://www.ncbi.nlm.nih.gov/pubmed/26137852
http://dx.doi.org/10.1038/mt.2015.121

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4817926/
https://www.ncbi.nlm.nih.gov/pubmed/26137852
http://dx.doi.org/10.1038/mt.2015.121

Ejemplares similares